BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30246028)

  • 41. Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.
    Chen GL; Lamirande EW; Cheng X; Torres-Velez F; Orandle M; Jin H; Kemble G; Subbarao K
    J Virol; 2014 Mar; 88(5):2867-76. PubMed ID: 24371061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*.
    Sheldon EA; Jeanfreau R; Sliman JA; Charenkavanich S; Rousculp MD; Dubovsky F; Mallory RM
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1142-50. PubMed ID: 23061976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
    Moser MJ; Hatta Y; Gabaglia C; Sanchez A; Dias P; Sarawar S; Kawaoka Y; Hatta M; Neumann G; Bilsel P
    Vaccine; 2019 Jul; 37(32):4533-4542. PubMed ID: 31280945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
    Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
    Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets.
    Cheng X; Zengel JR; Suguitan AL; Xu Q; Wang W; Lin J; Jin H
    J Infect Dis; 2013 Aug; 208(4):594-602. PubMed ID: 23656978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose.
    Smith JH; Papania M; Knaus D; Brooks P; Haas DL; Mair R; Barry J; Tompkins SM; Tripp RA
    Vaccine; 2012 Apr; 30(19):3026-33. PubMed ID: 22075083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages.
    Carlock MA; Ross TM
    Sci Rep; 2023 Sep; 13(1):15911. PubMed ID: 37741893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets.
    Chen Z; Zhou H; Kim L; Jin H
    J Virol; 2012 Mar; 86(5):2780-6. PubMed ID: 22190726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.
    Wohlbold TJ; Nachbagauer R; Xu H; Tan GS; Hirsh A; Brokstad KA; Cox RJ; Palese P; Krammer F
    mBio; 2015 Mar; 6(2):e02556. PubMed ID: 25759506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
    Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
    Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets.
    Khurana S; Verma S; Verma N; Crevar CJ; Carter DM; Manischewitz J; King LR; Ross TM; Golding H
    J Virol; 2011 Feb; 85(3):1246-56. PubMed ID: 21084473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge.
    Baz M; Boonnak K; Paskel M; Santos C; Powell T; Townsend A; Subbarao K
    mBio; 2015 Oct; 6(5):e01487-15. PubMed ID: 26489862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.
    Laurie KL; Horman W; Carolan LA; Chan KF; Layton D; Bean A; Vijaykrishna D; Reading PC; McCaw JM; Barr IG
    J Infect Dis; 2018 Jan; 217(4):548-559. PubMed ID: 29325138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
    Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
    Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.
    Gustin KM; Maines TR; Belser JA; van Hoeven N; Lu X; Dong L; Isakova-Sivak I; Chen LM; Voeten JT; Heldens JG; van den Bosch H; Cox NJ; Tumpey TM; Klimov AI; Rudenko L; Donis RO; Katz JM
    J Infect Dis; 2011 Nov; 204(10):1491-9. PubMed ID: 21957153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
    Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
    PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets.
    Huber VC; McCullers JA
    J Infect Dis; 2006 Mar; 193(5):677-84. PubMed ID: 16453263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza.
    Hossain MJ; Bourgeois M; Quan FS; Lipatov AS; Song JM; Chen LM; Compans RW; York I; Kang SM; Donis RO
    Clin Vaccine Immunol; 2011 Dec; 18(12):2010-7. PubMed ID: 22030367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.